Purification of recombinant proteins
Recombinant human Bax was produced as described (2) but the purification procedure was modified. The Bax eluted from the chitin colum n was dialyzed (12000 MW cutoff) at 4ºC for 24 hrs against 3L of 1m M EDTA, 10mM Tris-HCl, pH 8. Then it was dialy zed again for 24 hrs against 5L of 10 mM Tris-HCl pH 8 to remove all re maining DTT. Reco mbinant tBid w as purified as described (3) . Bcl-xL was purified as described (4 -6) . All proteins were filter-sterilized (0.2 m filter), gl ycerol added (10% fina l), rapidl y flash-frozen with ethanol and dr y-ice, and stored at -80 o C. Prote in concentration was deter mined after dialysis by the BCA method.
Western blot analysis
For all western blotting experiments, three 1mL mitochondrial suspensions (960 g/mL) were incubated at 30 o C under t he conditions and for the tim es indicated in the figure legends. The tri plicates were centrifuged (10,000 RCF f or 5 m in) and each resuspe nded into 200 µL of FH buffer. These were pooled together, m itochondria re pelleted and subjected to sodium carb onate treat ment as descri bed (7) . The pellet was resuspended in 50 L of 2% SDS and incubated for 1 hr on ice. Then, the detergent solubilized fraction was separated fr om the deter gent-insoluble fraction by centrifu gation and 30 µL used for PAGE/blotting analysis. VDAC served as loading control. Bax was probed with rabbit anti-Bax (Ab7977: 1:1000) and VDAC was probed with rabbit anti-VDAC anti-serum (1:1,000,000). Bot h the primary antibodies were probed with HRP tagged anti-rabbit secondary antibodies (1:2500 for Bax and 1:5000 for VDAC). Blots were developed with DAB as described in (8) .
Cytochrome c accessibility assay
The cy tochrome c oxidation or accessi bility assay was perfor med as describ ed previously (6) . Afte r appropriate treatment of 96 g/mL mitochondria with Bcl-2 family proteins, 100 L of this suspension was dispersed in 600 L of cy tochrome c oxidation assay buffer (equivalent to FH buffer (mannitol + KCl (total 300 mOs), 0.1 mM EGTA, 5 mM HEPES pH 7.5) of appropriate ionic strength supplemented with 5 mM DNP and 5 M anti mycin A) an d quickly assay ed for c ytochrome c oxidation b y adding 10 L of reduced cy tochrome c to a final concentration of ~25 M. Cytochrome c oxidation was measured as decline in absorbance at 5 50 nm. The rate of oxidatio n was calculated from the slope of the linear region of the absorbance chan ge measured for 2 minutes. Maxi mal rate of cytochrome c oxidation (corresponding to 100% perm eabilization) was determ ined by t he rate of c ytochrome c oxidation b y equivalent amount of hypotonically shocked mitochondria (at least 1 volume of mitochondrial suspension to 50 volumes of double distilled H 2 O). Hypotonic lysis breaks the MOM and exposes all the cytochrome oxidase to exogenous c ytochrome c. The % oxidation rate was calculated with maximal oxidation rate as 100% and rat e of oxidati on by control mitochondria (no treatment) as 0 %. Cytochrome oxidase activity was strongly sensitive to ionic strength, so control and maximal oxidation rates were determined for each salt concentr ation tested. The actual num erical values of control, Bax-tBid treated and maxi mal cytochrome c oxidation rates at 10 and 90mM KCl are presented (Fig S1A) for comparison.
Adenylate kinase (AK) assay
The assay was perfor med as described previously (6) . This assay measures the release o f the 24 kDa protein, adenylate kinase, from the IMS of mitochondria. In this coupled enzyme assay, NADP is reduced to form NADPH which has a strong abs orbance at 340 nm. (The oxidized form NADP does not have this absorbance). Prior to ass aying, 2.5 L of a mix of Hexokinase/Glucose-6-Phosphate Dehy drogenase ( 5 units each) was incubated in 350 L AK buffer ( 5 mM MgSO 4 , 10 mM glucose, 5 mM ADP, 0.2 mM NADP, 50 mM Tris, and pH 7.5) to re move r esidual ATP. After 2-3 m inute incubation, 150 L of mitochondrial supernatant was added to the AK buffer/ enzyme mix, and absorp tion was measured for 5 minutes at 340 nm. The initial linear slope of increase in absorption was taken as the rate of A K reaction. Since all other reaction com ponents ar e in excess, the concentration of AK is the rate-li miting factor. Hence the r ate of NADP H formation is a direct measure of am ount of AK released fro m mitochondria. Maximal rate of NADPH form ation, correspondi ng to 100% rel ease of AK from mitochondria, was measured from the activit y of su pernatant from equivalent am ount o f h ypotonically shocked mitochondria. The actual numerical values of AK ac tivity used as control ( 0% AK activity or no release of AK), Bax-tBid treated and l ysed (100% AK activ ity or complete release of AK) are presented in Fig  S1B for comparison.
Sulfite oxidase (SOX) assay
SOX is a 120 kDa IMS protein and its release fro m mitochondria was assay ed as described (9) . SOX reduces cy tochrome c using sulfite as the electron donor. Pri or to the assay , a one-to-one solution of 40 mM Na 2 SO 3 and 5 0 mg/ml oxidized cytochrom e c was made. Then 10 L of this sol ution ( 0.4 mM Na 2 SO 3 and 0.5 mg oxidized cy tochrome c final) was added to 50 0 L mitochondrial supernatant and the absorbance was quickl y measured at 550 nm for 5 minutes. Maxim al release was measured fro m the activity of supernatant from equivalent amount of hypotonically shocked mitochondria. SOX activity was strongly sensitive to ionic strength. Hence, the supernatant was supplemented with suitable amount of salt by diluti on from stock salt solution to adjust the ionic strength. The actual numerical va lues of SO X activity used as control (0% SOX activity or no release of SOX), Bax-tBid treated and lysed (100 % SOX activity or complete release of SOX) are presented in Fig S1C for comparison.
Measurement of fumarase activity
Fumarase is a matrix enzyme that reversibly converts malate to fumarate. Fumarase release was measured by a standard procedure (10) . Briefly 96 g/mL mitochondrial suspension in F H buffer was treated with varying conc entrations of digitonin (from 0.0025% to 0.1% in multiples of 2) for 5 m inutes at room temperature and centrifuged for 5 m inutes at 14000 RCF and supernatant collected. 500 L of th e supernatant was mixed with 500 L of fumarase assay buffer (50 mM malate, 50 mM Na 2 HPO 4 pH 7.3 ) and change in absorbance measur ed for 5 m inutes at 250 nm in quartz cuvettes to m easure formation of fumarate which shows strong absorban ce at 250 nm. Maxim al fu marase release correspondi ng t o 1 00% was obtained by treating equivalent amount of mitochondria with 0.2 % Triton-X100.
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FIGURE S1: Measured rates of enzym atic activity in a set of experim ents showing the rates prior to any treatment (control rates), the rate s after tBid/Bax treatment, and the maxim al rates after hypotonic shock. The influence of ionic stre ngth on som e of these rates is illustrated. By subtracting the control r ates and exp ressing the results as a p ercentage of the m aximal rates we correct for background rates a nd effects of i onic strength. Th e figure shows the rates of cytochrome c (25 M) o xidation (A), AK activity as m easured by absorbance (OD) change at 340nm (B) and SOX activity as m easured by abso rbance change at 550nm (C) recorded from 96g/mL mitochondrial suspensions that were either untreated (c ontrol), or treated with 17nM Bax and 120nM tBid or osm otically lysed (lysed). Incubations (30 m in) were in eithe r 10 o r 90mM KCl buffer. * represents P value < 0. 05 and ** represents P value < 0.01. n= 3. KCl buffer (solid lines) or 90m M KCl buffer (d ashed lines) and the rate of cytochrom e c oxidation was determined at different tim e intervals. * represents P va lue < 0.05, ** -P value < 0.01. n = 3.
FIGURE S6
: Bcl-xL m ediated inhibition of MOMP is sensitive to tBid con centration. Mitochondrial suspensions were incubated w ith 17nM m onomeric Bax, either 24nM or 120nM tBid, witho ut Bcl-xL o r with 48n M Bcl-xL in 10m M KCl buffer or 90m M KCl buffer for 30 minutes at 30 o C. Then, the ex tent of AK release was dete rmined f or the dif ferent trea tments. The differences in the inhibitory effects of Bcl-xL at 10 and 90 m M were statistically significant with P<0.0001 at both tBid concentrations. n = 3. 
